- Fractal hyperbolic field — the geometry of biological information

Fractal Biomedical Hyperbolic Field System

Patented technology for informational management of biological processes through reverse engineering of cells and hyperbolic field generators

Who We Are?

Advanced Scientific Research Projects (ASRP) is an international research organization operating through two headquarters rooted in the history of space exploration. Our US Headquarters is located in St. Petersburg, Florida, USA. Our Kazakhstan Space Research Headquarters is located at the Baikonur Cosmodrome — the world's first and most historic spaceport, where Sputnik 1 was launched and Yuri Gagarin began humanity's first journey into space. These two locations symbolize the convergence of the world's greatest spaceflight traditions, reflecting ASRP's commitment to international scientific collaboration in aerospace engineering, biomedical research, AI, and emerging technologies.

Our Mission

To pioneer a new paradigm of medicine — one that treats previously incurable diseases by restoring and correcting biological processes at the level of cellular electromagnetic information, replacing or complementing conventional pharmacology.

Project Goal

To develop, validate, and patent a fractal hyperbolic field platform that creates new types of non-invasive therapeutic agents — alternatives to antibiotics and anti-tumor drugs — and to demonstrate through peer-reviewed studies that this technology works on fundamentally new principles.

Biomedical Fractal System Overview

A patented technology for informational management of biological processes based on reverse engineering of cells and hyperbolic field generators. Learn how HFS creates space-time structures in biological carriers to regulate cell division, metabolism, regeneration, and more.

00:00:0000:00:00

Patent Technology

Hyperbolic Field Emitter Technology:

Description:

The core of the FBHFS patent is a multi-node emitter array that generates structured hyperbolic field patterns from reverse-engineered cellular electromagnetic signatures. The system uses fractal geometry to encode biological information into field configurations, creating space-time structures in biological carriers that can modulate cell division, metabolism, and regeneration. The emitter platform has evolved from a 0.7W prototype to a 60W average / 144W peak system with a 6-node array producing clean sine wave output, ensuring biologically relevant field intensities with signal purity critical for reproducible effects.

Biomedical Applications:

Description:

FBHFS technology demonstrates measurable effects across multiple biomedical domains. Blood plasma coagulation studies show modified clotting kinetics under controlled hyperbolic field exposure. Neurogenesis research indicates potential for non-invasive cognitive enhancement through cardiac neuroendocrine center stimulation. Multi-organ therapeutic protocols explore applications in tissue regeneration, metabolic regulation, and inflammatory response modulation. All applications operate through information transfer rather than thermal or ionizing mechanisms, establishing a fundamentally new paradigm in biomedical intervention.

Research Integration:

Description:

The FBHFS patent serves as the technological backbone connecting all ASRP hyperbolic field studies. The Blood Plasma Study validates foundational biophysical effects. The DAAT Crystal Study explores cognitive-crystal interaction using FBHFS-derived emitters. The Agricultural Study demonstrates cross-kingdom applicability on plant systems. The Saccharomyces Study provides microbial-scale validation with computer vision analysis. Together, these studies form a comprehensive evidence base for the universal applicability of fractal hyperbolic field technology across biological scales and kingdoms.

Patent

Fractal Biomedical Hyperbolic Field System

KZ 2025/1095.1

The Fractal Biomedical Hyperbolic Field System is protected under Kazakhstan patent KZ 2025/1095.1. Full patent documentation, including technical specifications and experimental validation data, is available in the open-access repository.

Patent documentation

Related Research

The FBHFS patent technology connects all ASRP hyperbolic field research through shared emitter platforms, experimental methodologies, and analytical frameworks.

Related research

Research Team

An interdisciplinary group of specialists in agronomy, hyperbolic field physics, AI analysis, and experimental design.

Valeria Ovseannicova

Valeria Ovseannicova

CBE (Chief Biomedical Engineer), Founder ASRP

Hyperbolic field physics, research management and coordination, lead researcher and developer of hardware and software.

Mykhailo Kapustin

Mykhailo Kapustin

CTO (Chief Technology Officer), Founder ASRP

AI/ML infrastructure development, image analysis automation, multi-provider LLM integration.

Ivan Savelyev

Ivan Savelyev

CSO (Chief Scientific Oficer)

Science Director and Editor-in-Chief.

Kyryl Zmiienko

Kyryl Zmiienko

SAIE (Senior Artificial Intelligence Engineer)

Developed and trained computer vision (CV) models for coagulation analysis, results validation.

Denis Banchenko

Denis Banchenko

CEO (Chief Executive Officer), Founder ASRP

Project lead in the theory, physics, and geometry of hyperbolic fields, physics of time, as well as engineering and hardware solutions in the field.

Contact our team

Send us a note to get the conversation started